Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosemary extract versus ketamine gargle for post-intubation sore throat and hoarseness
IRCT20160307026950N50Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of ketamine (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Sore throat and Hoarseness. Started Dec 2022; status: completed.
02
Drugs
ketamine
Beyond the preview
Go deeper on IRCT20160307026950N50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N50.